Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - A [11C]DASB PET study

Journal of Neural Transmission

Volumn 114, Issue 12, 2007, Pages 1603-1609

  Reimold, M ^a   Smolka, M N ^b   Zimmer, A ^b   Batra, A ^a   Knobel, A ^c   Solbach, C ^a   Mundt, A ^c   Smoltczyk, H U ^a   Goldman, D ^d   Mann, K ^b   Reischl, G ^a   Machulla, H J ^a   Bares, R ^a   Heinz, A ^b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

5 HTT; 5 HTTLPR; OCD; SERT; Thalamus

Indexed keywords

3 AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL)BENZONITRILE C 11; SEROTONIN; SEROTONIN TRANSPORTER; TRACER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN LEVEL; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; GENOTYPE; HUMAN; MALE; MESENCEPHALON; OBSESSIVE COMPULSIVE DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RATING SCALE; SEROTONINERGIC SYSTEM; SMOKING; THALAMUS;

ADULT; AGE FACTORS; ANILINE COMPOUNDS; BRAIN; FEMALE; GENOTYPE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; POSITRON-EMISSION TOMOGRAPHY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX FACTORS; SMOKING; SULFIDES;

EID: 36749032152     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0785-6     Document Type: Article

References (53)

1. GE Alexander MR DeLong PL Strick 1986 Parallel organization of functionally segregated circuits linking basal ganglia and cortex Ann Rev Neurosci 9 357 381
2. M Asberg L Thoren L Bertilsson 1982 Clomipramine treatment of obsessive-compulsive disorder: biochemical and clinical aspects Psychopharmacol Bull 18 13 21
3. LR Baxter ME Phleps JC Mazziotta BH Guze JM Schwartz CE Selin 1987 Local cerebral glucose metabolic rates in obsessive-compulsive disorder Arch Gen Psychiatry 44 211 218
4. LR Baxter JM Schwartz KS Bergman 1992 Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder Arch Gen Psychiatry 9 681 689
5. AT Beck CH Ward M Mendelson J Mock J Erbaugh 1961 An inventory for measuring depression Arch Gen Psychiatry 4 561 571
6. KC Berridge JW Aldridge KR Houchard X Zhuang 2005 Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's BMC Biol 3 4
7. A Brooks TA Pigott JL Hill 1998 Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioural and biological results Psychiatry Res 79 2077 2082
8. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD (1994) The Temperament and Character Inventory (TCI): A guide to its development and use. Center for Psychobiology of Personality, St. Louis, MO
9. JL Cummings 1993 Frontal-subcortical circuits and motor behavior Arch Neurol 50 873 880
10. MB First RL Spitzer M Gibbon J Williams 1997 Structured clinical interview for DSM-IV personality disorders (SCID-II) American Psychiatric Press Washington, DC
11. MB First RL Spitzer M Gibbon J Williams 2001 Structured clinical interview for DSM-IV-TR axis I disorders, Research Version, Patient Edition With Psychotic Screen Biometrics Research, New York State Psychiatric Institute New York
12. 11C-McN 5652 in healthy humans J Nucl Med 45 682 694
13. WK Goodman LH Price SA Rasmussen 1989a The Yale-Brown Obsessive Compulsive Scale. I: Development, use, and reliability Arch Gen Psychiatry 46 1006 1011
14. WK Goodman LH Price SA Rasmussen 1989b The Yale-Brown Obsessive Compulsive Scale. II: Validity Arch Gen Psychiatry 46 1012 1016
15. WK Goodman LH Price PL Delgado 1990 Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine Arch Gen Psychiatry 47 577 585
16. A Heinz JD Higley JG Gorey 1998a In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates Am J Psychiatry 155 1023 1028
17. 123I]h-CIT SPECT correlates of vocal tic severity Neurology 51 1069 1074
18. A Heinz 1999 Neurobiological and anthropological aspects of compulsions and rituals Pharmacopsychiatry 32 223 229
19. A Heinz DW Jones C Mazzanti 2000a A Relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity Biol Psychiatry 47 643 649
20. A Heinz D Goldman DW Jones 2000b Genotype influences in vivo dopamine transporter availability in human striatum Neuropsychopharmacology 22 133 139
21. A Heinz DW Jones G Bissette 2002 Relationship between cortisol and serotonin metabolites and transporters in alcoholism Pharmacopsychiatry 35 127 134
22. A Heinz DW Jones K Zajicek 2004 Depletion and restoration of endogenous monoamines affects beta-CIT binding to serotonin but not dopamine transporters in non-human primates J Neural Transm Suppl 68 29 38
23. S Hesse U Müller T Lincke 2005 Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder Psychiatry Res Neuroimaging 140 63 72
24. 11C]DASB Eur J Nucl Med 27 1719 1722
25. XZ Hu G Oroszi J Chun TL Smith D Goldman MA Schuckit 2005 An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk Alcohol Clin Exp Res 29 8 16
26. XZ Hu RH Lipsky G Zhu LA Akhtar J Taubman BD Greenberg K Xu PD Arnold MA Richter JL Kennedy DL Murphy D Goldman 2006 Serotonin transporter promotor gain-of-function genotypes are linked to obsessive-compulsive disorder Am J Hum Genet 78 815 826
27. R Hummerich G Reischl W Ehrlichmann HJ Machulla A Heinz P Schloss 2004 DASB - in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as a PET tracer J Neurochem 90 1218 1226
28. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain J Cereb Blood Flow Metab 23 1096 1112
29. Innis RB, Cunningham VJ, Delforge J, et al (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (in press)
30. TR Insel EA Mueller I Alterman M Linnoila DL Murphy 1985 Obsessive-compulsive disorder and serotonin: is there a connection? Biol Psychiatry 20 1174 1185
31. 123I]β-CIT: pharmacological characterization of brain uptake in non-human primates Synapse 13 295 309
32. LT Laux P Glanzmann P Schaffner CD Spielberger 1981 Das State-Trait-Angstinventar (STAI) Beltz Weinheim
33. KP Lesch D Bengel A Heils 1996 Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 274 1527 1531
34. DA McCormick 1992 Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity Prog Neurobiol 39 337 388
35. JE Monckton DA McCormick 2002 Neuromodulatory role of serotonin in the ferret thalamus J Neurophysiol 87 2124 2136
36. D Perani C Colombo S Bressi 1995 [F-18]FDG PET study in obsessive-compulsive disorder. A clinical/metabolite correlation study after treatment Br J Psychiatry 166 244 250
37. O Pogarell C Hamann G Pöpperl 2003 Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder Biol Psychiatry 54 1406 1413
38. N Praschak-Rieder A Wilson D Hussey 2005 Effects of tryptophan depletion on the serotonin transporter in healthy humans Biol Psychiatry 58 825 830
39. 11C] DASB positron emission tomography study. Biol Psychiatry (published online)
40. 11C]DASB is affected by serotonin transporter genotype J Neural Transm 114 635 639
41. 11C]DASB PET study. Mol Psychiatry (in press)
42. 11C] McN 5652 Biol Psychiatry 54 1414 1421
43. 11C]DASB and application in a remote-controlled high yield synthesis Radiochim Acta 92 341 344
44. 123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers Synapse 41 275 284
45. SE Swedo HL Leonhard 1995 Childhood movement disorders and obsessive compulsive disorder J Clin Psychiatry 55 Suppl 32 37
46. 11C-DASB in healthy humans Synapse 55 164 175
47. P Thoren M Asberg B Bertilsson B Mellstrom F Sjoqvist L Traskman 1980 Clomipramine treatment of obsessive-compulsive disorder: II. Biochemical aspects Arch Gen Psychiatry 37 1289 1294
48. 123I]β-CIT SPECT Am J Psychiatry 161 2201 2206
49. CH van Dyck RT Malison LK Jacobsen 2005 Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene J Nucl Med 46 745 751
50. SS Wolf DW Jones MB Knable 1996 Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding Science 273 1225 1227
51. 123I]-β-CIT SPECT Imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers. Neuropsychopharmacology Published online 27 December 2006
52. J Zohar TR Insel 1987 Obsessive-compulsive dirorder: psychobiological approaches to diagnosis, treatment and pathophysiology Biol Psychiatry 22 667 687
53. J Zohar EA Mueller TR Insel RC Rachel-Kadouch DL Murphy 1987 Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls Arch Gen Psychiatry 44 946 951